Wyeth Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WYETH PHARMS
WYETH PHARMS has thirty-one approved drugs.
There are two US patents protecting WYETH PHARMS drugs.
There are fifty-six patent family members on WYETH PHARMS drugs in thirty countries and thirty-six supplementary protection certificates in thirteen countries.
Summary for Wyeth Pharms
| International Patents: | 56 |
| US Patents: | 2 |
| Tradenames: | 29 |
| Ingredients: | 18 |
| NDAs: | 31 |
Drugs and US Patents for Wyeth Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | PIPRACIL | piperacillin sodium | INJECTABLE;INJECTION | 062750-001 | Oct 13, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wyeth Pharms | PROTONIX | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020987-001 | Feb 2, 2000 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wyeth Pharms Inc | FOLVITE | folic acid | TABLET;ORAL | 005897-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wyeth Pharms Inc | NORPLANT SYSTEM IN PLASTIC CONTAINER | levonorgestrel | IMPLANT;IMPLANTATION | 020088-001 | Dec 10, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wyeth Pharms | ZOSYN | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050684-003 | Oct 22, 1993 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Wyeth Pharms | OVRAL | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 016672-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Wyeth Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | PREMPRO (PREMARIN;CYCRIN) | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020303-001 | Dec 30, 1994 | RE36247 | ⤷ Start Trial |
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-004 | Dec 28, 1993 | 5,916,923 | ⤷ Start Trial |
| Wyeth Pharms | LO/OVRAL-28 | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 017802-001 | Approved Prior to Jan 1, 1982 | 3,666,858 | ⤷ Start Trial |
| Wyeth Pharms | DUAVEE | bazedoxifene acetate; estrogens, conjugated | TABLET;ORAL | 022247-001 | Oct 3, 2013 | 6,479,535 | ⤷ Start Trial |
| Wyeth Pharms Inc | LODINE | etodolac | CAPSULE;ORAL | 018922-002 | Jan 31, 1991 | 3,939,178 | ⤷ Start Trial |
| Wyeth Pharms | PREMPRO | estrogens, conjugated; medroxyprogesterone acetate | TABLET;ORAL-28 | 020527-003 | Jan 9, 1998 | RE36247 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for WYETH PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg and 40 mg | ➤ Subscribe | 2004-02-02 |
| ➤ Subscribe | Tablets | 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg | ➤ Subscribe | 2005-11-03 |
| ➤ Subscribe | For Injection | 12 g/1.5 g per vial (pharmacy bulk) | ➤ Subscribe | 2011-12-06 |
| ➤ Subscribe | Tablets | 0.09 mg/0.02 mg | ➤ Subscribe | 2007-10-05 |
International Patents for Wyeth Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2561010 | ⤷ Start Trial |
| Colombia | 5690538 | ⤷ Start Trial |
| Ukraine | 85703 | ⤷ Start Trial |
| Argentina | 048527 | ⤷ Start Trial |
| Canada | 2539982 | ⤷ Start Trial |
| Norway | 339714 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Wyeth Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1380301 | CA 2009 00017 | Denmark | ⤷ Start Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629 |
| 0502314 | SPC/GB02/037 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: TELMISARTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/02/213/001 20020419; UK EU/1/02/213/002 20020419; UK EU/1/02/213/003 20020419; UK EU/1/02/214/004 20020419; UK EU/1/02/213/005 20020419; UK EU/1/02/213/006 20020419; UK EU/1/02/213/007 20020419; UK EU/1/02/213/008 20020419; UK EU/1/02/213/009 20020419; UK EU/1/02/213/010 20020419 |
| 1453521 | 39/2015 | Austria | ⤷ Start Trial | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
| 0802183 | 09C0048 | France | ⤷ Start Trial | PRODUCT NAME: BAZEDOXIFENE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/09/511/001 DU 20090417; REGISTRATION NO/DATE AT EEC: EU/1/09/511/001-004 DU 20090417 |
| 1539166 | SPC/GB13/070 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: THE COMBINATION OF: (A) DEXTROMETHORPHAN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, E.G. DEXTROMETHORPHAN HYDROBROMIDE AND IN PARTICULAR DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE; AND (B) QUINIDINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, E.G. Q; REGISTERED: UK EU/1/13/833 20130626 |
| 1453521 | C201630040 | Spain | ⤷ Start Trial | PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
